Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 2Phase 2/3 2Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Mouth Neoplasms 1Lymphoma, Follicular 1Influenza, Human 1Dysgeusia 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Starch × Clear all
NCT02108366 2019-10-21

Treatment of Severe Influenza A Infection

The University of Hong Kong

Phase 3 Completed
107 enrolled
Lymphoid

Influenza, Human, Lymphoma, Follicular

NCT03824925 2019-01-31

Efficacy of Zinc on Concurrent Chemo-radiotherapy Induced Taste Alterations

Dow University of Health Sciences

Phase 3 Completed
70 enrolled
Head & Neck

Dysgeusia, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡